Palantir's Karp renews attacks on frontier AI labs that are 'trying to drug addict us'

Skip NavigationMarketsPre-MarketsU.S. MarketsCurrenciesPrediction MarketsCryptocurrencyFutures & CommoditiesBondsFunds & ETFsBusinessEconomyFinanceHealth & ScienceMediaReal EstateEnergyClimateTransportationInvestigationsIndustrialsRetailWealthSportsLifeSmall BusinessInvestingPersonal FinanceFintechFinancial AdvisorsOptions ActionETF StreetBuffett ArchiveEarningsTrader TalkTechCybersecurityAIEnterpriseInternetMediaMobileSocial MediaCNBC Disruptor 50Tech GuidePolitics & PolicyWhite HousePolicyDefenseCongressExpanding OpportunityVideoLatest VideoFull EpisodesLivestreamLive AudioLive TV ScheduleCNBC PodcastsCEO InterviewsCNBC DocumentariesDigital OriginalsWatchlistInvesting ClubTrust PortfolioAnalysisTrade AlertsMeeting VideosHomestretchJim's ColumnsEducationSubscribePROPro NewsJosh BrownMike SantoliCalls of the DayMy PortfolioLivestreamFull EpisodesStock ScreenerMarket ForecastOptions InvestingChart InvestingSubscribeLivestreamMenuMake ItselectUSAINTLLivestreamSearch quotes, news & videosLivestreamWatchlistSIGN INCreate free accountMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting ClubPROLivestreamMenu (function() { const userMembershipOnLastVisit = localStorage.getItem("cnbcMeta__cachedUserMembership"); if (!userMembershipOnLastVisit) { // If no user membership is stored, user is likely not logged in. // These users will typically see the banner. return; } const { isPro, isInvestingClubUser } = JSON.parse(userMembershipOnLastVisit); if (!(isPro || isInvestingClubUser)) { // We’re rendering the top banner for users who are not pro or investing club members. return; } // Hide the banner for pro and investing club users. const style = document.createElement("style"); style.id = "top-banner-placeholder-style"; style.innerHTML = "[data-top-banner-placeholder] { display: none; }"; document.head.appendChild(style); })() AI EffectAI at WorkAI InsightsAI ImpactAI EventsAI AgePalantir's Karp renews attacks on frontier AI labs that are 'trying to drug addict us'Published Mon, Aug 3 20265:30 PM EDTUpdated 6 Hours AgoSeema Mody@SeemaCNBCWATCH LIVEKey PointsPalantir CEO Alex Karp is deepening his attack on the leading AI labs.In an exclusive interview with CNBC, Karp said enterprises need to protect their data or risk losing their business to model makers.Karp said Chinese models can't be blamed for distilling U.S. models when the frontier labs "distilled all the value of IP, everywhere."In this articlePLTRFollow your favorite stocksCREATE FREE ACCOUNTwatch nowVIDEO14:4814:48Watch CNBC’s full interview with Palantir CEO Alex KarpNews VideosPalantir CEO Alex Karp doubled down on his criticism of the frontier artificial intelligence labs on Monday, arguing that enterprises shouldn't be forced to give up their intellectual property to work with model makers."We have people trying to drug addict us to a future they [frontier AI models] believe they control," Karp said in an exclusive interview with CNBC. "Now, I've spent a lot of time with Dario [Amodei] and the Anthropic crew. They want to tell you we have to march into a future where we own nothing, where our businesses aren't profitable, where none of us have jobs, and where our adversaries win." Instead, Karp said, enterprises should control their own models and work with companies like Palantir that offer an application layer that sits on top of a company's stack, thereby allowing the business to keep the data in-house.Anthropic and OpenAI have said over the last month that customer data is secure and isn't used to train their models. OpenAI went as far as to say businesses must explicitly opt in if they want their data used for model improvement.Karp isn't buying it."Every enterprise we interact with, and that includes some of the biggest and m